section name header

Pronunciation ⬇

mag-NEE-zhum SUL-fate

Classifications ⬆ ⬇

Therapeutic Classification: mineral and electrolyte replacements/supplements

Pharmacologic Classification: minerals electrolytes

Indications ⬆ ⬇

High Alert


Unlabeled Use:

Action ⬆ ⬇

  • Essential for the activity of many enzymes.
  • Plays an important role in neurotransmission and muscular excitability.
Therapeutic effects:
  • Replacement in deficiency states.
  • Resolution of eclampsia.

Pharmacokinetics ⬆ ⬇

Absorption: IV administration results in complete bioavailability; well absorbed from IM sites.

Distribution: Widely distributed to tissues

Metabolism/Excretion: Excreted primarily by the kidneys.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

(anticonvulsant effect)

ROUTEONSETPEAKDURATION
IM60 minunknown3–4 hr
IVimmediateunknown30 min

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: arrhythmias, bradycardia, hypotension

Derm: flushing, sweating

GI: diarrhea

Metab: hypothermia

MS: muscle weakness

Neuro: drowsiness

Resp: ↓respiratory rate

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Treatment of Deficiency

Seizures Associated with Eclampsia/Pre-Eclampsia

Torsades de Pointes

Bronchodilation

Parenteral Nutrition

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

IV Administration:

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆